Cardiovascular diseases (CVDs) are the leading cause of death in both developed and developing countries. Endothelial progenitor cells (EPCs) are derived from hematopoietic stem cells with powerful function of angiogenesis. There are many studies on the relation between coronary heart disease and circulating EPCs. In this review, we discuss biological characteristics of endothelial progenitor cells, some influencing factors of the number and function of EPCs, and the role of EPCs in the treatment of cardiovascular disease. At last, we bring some perspectives on the future of endothelial progenitor cell therapy.
| INTRODUCTION
In the past few decades, cardiovascular diseases (CVDs) are one of the most common and important causes of death in both developed and developing countries. 1 Many CVDs, such as atherosclerosis, hypertension, and chronic heart failure, are closely related to endothelial dysfunction, which may reduce arterial elasticity, and eventually leading to CVDs. [2] [3] [4] Under the circumstances, a great number of studies have been done on endothelial tissue and angiogenesis, which show us that different kinds of molecular, cellular, and functional changes in the endothelium tissue may affect the process of angiogenesis. [5] [6] [7] Blood vessel formation is the basic process of the regeneration and development of organisms and tissues. 8 More and more studies demonstrate that circulating endothelial progenitor cells (EPCs) derived from the bone marrow conduce to angiogenesis and normal vascular homeostasis. 9 Therefore, transplantation of exogenous EPCs has gradually turned into a novel cell therapy for CVDs.
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| END OTHELIAL PROGENITOR CELLS (EPCs)
| Characteristics of EPCs
It was considered that differentiation of mesodermal cells to angioblasts and subsequent endothelial differentiation was a specific process occurring in embryonic development for a long time. This concept was overthrown in 1997 when Asahara et al 13 
| Mobilization and homing of EPCs
The initial vascular plexus is then remodeled and refined through proliferation and migration of endothelial cells to form new vessels from the preexisting ones during angiogenesis. 27 During the process, ECs are tightly held together to form the inner lumen of blood vessels. 28 Owing to the close junction, ECs can control paracellular permeability and the entry and exit of molecules. 
| INFLUE NCING FACTOR S OF THE NUMBER AND FUNCTION OF EPCs
Vascular endothelial cell is a layer of cell covering the inner side of vascular wall and plays an essential role in almost all vascular functions. 32 A variety of factors may damage endothelial cells, which include physical injuries, biochemical injuries, and immune-mediated damages. When these happen, ECs are disabled to maintain the homeostasis, which is named as endothelial dysfunction and may lead to cardiovascular diseases. 2, 33, 34 The pathophysiology of endothelial dysfunction is very complicated, and many mechanisms are related to it. Among them, oxidative stress is recognized by the most people. In the state of oxidative stress, the production of reactive oxygen species (ROS) exceeds the ability of endogenous oxygen radicals scavenging enzyme systems, causing the reduction in NO, a substance produced by endothelial cells through eNOS activation. 35 NO takes effect both in EPC mobilization and in EPC migration and proliferation and promote angiogenesis. It is due to the ability of EPCs to assemble and repair at the site of vascular damage that there are an increasing number of researches involving angiogenesis in the therapeutic use of EPCs.
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In patients with CAD, as the severity of the disease increases, the number of EPCs and circulating EPCs gradually decreases. [37] [38] [39] This may be the result of endothelial dysfunction in patients with CAD. 37 The coronary artery of the patients with coronary heart disease has endothelium-dependent vasodilatation, which not only involves the coronary artery, but also often involves the peripheral arteries.
Therefore, the elastic function of the peripheral arteriole can be clearly defined by the detection of the radial pulse wave, which reflects the function of the vascular endothelium itself. 40 regulation, and as a result, aging leads to decreased arterial elasticity and the changes in the function and structure of the artery wall. In the process of aging, the production of free radicals is not balanced with the effectiveness of antioxidants. 30 Increased ROS level will potentially stimulate chronic inflammation, eventually leading to impaired EPCs mobilization. 30 Vascular senescence is an important factor in the aging of the human body.
Fluid shear stress is the frictional tangential force imposed on the vessel wall when blood flow through a vessel. 45 Obi et al 46 demonstrated that when cultured EPCs are exposed to shear stress in a flow-loading device, their bioactivities increased significantly in proliferation, anti-apoptosis, migration, production of bioactive substances, and antithrombosis. Xia et al 47 showed that shear stress preconditioning reinforced the migration, adhesion, and re-endothelialization competencies in both young and elderly EPCs, which suggested that the upregulation of the shear stress contributes to the enhancement of endothelialization ability of endothelial progenitor cells.
Physical exercise is another risk factor for CAD, and it causes increased NO production. Gando et al 48 Hypertension is a common risk factor for the incidence of vascular disease. Wang et al 52 indicated that impaired endothelial function and decreased arterial elasticity persist in the human body though blood pressure of hypertensive patients was controlled through drugs. Therefore, the optimal therapy for patients with hypertension
is not just to lower blood pressure, but also to improve vascular damage. 
| TH E R OLE OF EPCs IN THE TRE ATMENT OF CARD IOVASCULAR DISEASE
Since EPCs have many effective characteristics, including easiness to gain from the peripheral blood, powerful angiogenic and vasculogenic effects, and the stability of the lineage and a reduced risk of tumorigenicity, EPCs is more and more used in the clinic. 
| Endothelial progenitor cell therapy
Based on the previous studies, it is widely known that through mobilization and homing of bone marrow-derived EPCs, the process of angiogenesis can be started and tissue ischemia for CAD can be alleviated. 36 Since this new treatment is at the emerging stage, many studies have discussed EPCs as a cellular candidate for regenerative therapies, and more data from the ongoing trials will help to establish the safety of EPC treatment. 56 However, questions still remain with regard to safety and efficacy and further research is needed.
| CONCLUSION S AND PE RSPECTIVES
Endothelial progenitor cells are important therapeutic targets in the field of regenerative medicine. Since the discovery of EPCs in adult blood circulation, the mechanism of recruitment, mobilization, homing and differentiation has been gradually recognized. Nevertheless, further research on its molecular biological process will help clarify how to optimize biological conditions to improve angiogenesis in patients. In the current situation, genetic modification of EPCs before transplantation may become a new research hot spot.
Although there are still many problems ahead, we have reason to believe that EPCs can be applied to the clinical treatment of coronary heart disease in the near future.
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